Literature DB >> 29210318

Inhalation device options for the management of chronic obstructive pulmonary disease.

Michael DePietro1, Ileen Gilbert1, Lauren A Millette1, Michael Riebe2.   

Abstract

Chronic obstructive pulmonary disease (COPD) is characterized by chronic respiratory symptoms and airflow limitation, resulting from abnormalities in the airway and/or damage to the alveoli. Primary care physicians manage the healthcare of a large proportion of patients with COPD. In addition to determining the most appropriate medication regimen, which usually includes inhaled bronchodilators with or without inhaled corticosteroids, physicians are charged with optimizing inhalation device selection to facilitate effective drug delivery and patient adherence. The large variety of inhalation devices currently available present numerous challenges for physicians that include: (1) gaining knowledge of and proficiency with operating different device classes; (2) identifying the most appropriate inhalation device for the patient; and (3) providing the necessary education and training for patients on device use. This review provides an overview of the inhalation device types currently available in the United States for delivery of COPD medications, including information on their successful operation and respective advantages and disadvantages, factors to consider in matching a device to an individual patient, the need for device training for patients and physicians, and guidance for improving treatment adherence. Finally, the review will discuss established and novel tools and technology that may aid physicians in improving education and promoting better adherence to therapy.

Entities:  

Keywords:  Inhaler; adherence; chronic obstructive pulmonary disease; dry powder inhaler; nebulizer; pressurized metered-dose inhaler; soft mist inhaler

Mesh:

Substances:

Year:  2017        PMID: 29210318     DOI: 10.1080/00325481.2018.1399042

Source DB:  PubMed          Journal:  Postgrad Med        ISSN: 0032-5481            Impact factor:   3.840


  7 in total

Review 1.  Physical stability of dry powder inhaler formulations.

Authors:  Nivedita Shetty; David Cipolla; Heejun Park; Qi Tony Zhou
Journal:  Expert Opin Drug Deliv       Date:  2019-12-13       Impact factor: 6.648

2.  Micro-fluidic Spray Freeze Dried Ciprofloxacin Hydrochloride-Embedded Dry Powder for Inhalation.

Authors:  Yingjie Chen; Shen Yan; Shengyu Zhang; Quanyi Yin; Xiao Dong Chen; Winston Duo Wu
Journal:  AAPS PharmSciTech       Date:  2022-08-02       Impact factor: 4.026

Review 3.  Inhalation Technique Errors with Metered-Dose Inhalers Among Patients with Obstructive Lung Diseases: A Systematic Review and Meta-Analysis of U.S. Studies.

Authors:  Soojin Cho-Reyes; Bartolome R Celli; Carole Dembek; Karen Yeh; Maryam Navaie
Journal:  Chronic Obstr Pulm Dis       Date:  2019-07-24

Review 4.  Review of Drug Development Guidance to Treat Chronic Obstructive Pulmonary Disease: US and EU Perspectives.

Authors:  Aernout van Haarst; Lorcan McGarvey; Sabina Paglialunga
Journal:  Clin Pharmacol Ther       Date:  2019-07-23       Impact factor: 6.875

5.  Device use errors with soft mist inhalers: A global systematic literature review and meta-analysis.

Authors:  Maryam Navaie; Carole Dembek; Soojin Cho-Reyes; Karen Yeh; Bartolome R Celli
Journal:  Chron Respir Dis       Date:  2020 Jan-Dec       Impact factor: 2.444

6.  Patients' usability of seven most used dry-powder inhalers in COPD.

Authors:  Roberto W Dal Negro; Paola Turco; Massimiliano Povero
Journal:  Multidiscip Respir Med       Date:  2019-09-13

7.  In Vitro Effect of Different Airflow Rates on the Aerosol Properties of Nebulized Glycopyrrolate in the eFlow® Closed System and Tiotropium Delivered in the HandiHaler®.

Authors:  Jill A Ohar; Andrea Bauer; Sanjay Sharma; Shahin Sanjar
Journal:  Pulm Ther       Date:  2020-08-18
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.